Co-primary end points were the incidence of OINV and the time-weighted sum of pain intensity differences over 24 hours (SPID24). RESULTS: Relative to HC/APAP treatment alone, CL-108 treatment reduced OINV by 64% (P < 0.001). Treatment with CL-108 si
…Search Page
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1983 | 1 |
1988 | 1 |
1993 | 1 |
2000 | 2 |
2013 | 1 |
2016 | 4 |
2019 | 1 |
2020 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 0 |